Uploaded on Oct 19, 2020
The recent study of Reports and Data on the suggests that the Neurodiagnostics market will be valued at USD 25.14 billion, growing at a CAGR of 7.8%. The study involves the analysis of the market for Neurodiagnostics, which consists of a series of diagnostic tests and medical procedures conducted to identify the malfunctions of the central nervous system.
Global Neurodiagnostics market analysis major competitor and strategies regional outlook 2020 to 2027
Neurodiagnostic
s Market To
Reach USD
25.14 Billion By
2026
www.reportsanddata.com
Market
The recent study of Reports and Data Son uthem suggmests athart tyhe Neurodiagnostics market will be valued
at USD 25.14 billion, growing at a CAGR of 7.8%. The study involves the analysis of the market for
Neurodiagnostics, which consists of a series of diagnostic tests and medical procedures conducted to
identify the malfunctions of the central nervous system. It involves the monitoring and analysis of the
nervous system, which will enable the efficient initiation of treatment procedures. The simple blockage
of the pathway of neuron flow can lead to the emergence of complex neurological disorders like
Parkinson’s and Multiple Sclerosis. The mental illness can be responsible for about 33% of a person’s
lived disability and leads to the reduction of the quality of life. The market is characterized by the
adoption of novel technologies beginning from imaging technologies to the discovery of digital
biomarkers, which has helped to combat the global burdens of mental and neurological disorders.
Read More @ https://www.reportsanddata.com/report-detail/neurodiagnostics-market
Market
Key players include GE Healthcare, SSiemuenms Heamlthinaeerrs, yPhilips Healthcare, Canon Medical Systems
Corporation, Hitachi Medical Corporation, Nihon Kohden Corporation, Fonar Corporation, Neusoft
Medical Systems Co., Ltd. NeuroNexus Technologies, Inc. and Lifelines Neurodiagnostic Systems, Inc
Technology Type (Revenue, USD Million; 2016–2026)
Neuroimaging Technology, In Vitro Diagnosis, Neuroinformatics
Disease Type (Revenue, USD Million; 2016–2026)
Alzheimer’s Disease, Migraine, Parkinson’s Disease, Epilepsy, Stroke, Multiple sclerosis,
Neurodegeneration, Others
End Use (Revenue, USD Million; 2016–2026)
Hospital and Clinics, Diagnostic Laboratories, Others
About Us
Reports and Data is a market research and consulting
company that provides syndicated research reports,
customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target and
analyze consumer behavior shifts across demographics, across
industries and help client’s make a smarter business decision.
We offer market intelligence studies ensuring relevant and
fact-based research across a multiple industries including
Healthcare, Technology, Chemicals, Power, and Energy. We
consistently update our research offerings to ensure our
clients are aware about the latest trends existent in the
market. Reports and Data has a strong base of experienced
analysts from varied areas of expertise.
John Watson
JohnH eWada otfs Bounsiness Development
HeadR oefp oBrutss Ainneds Ds aDtae |v Weleobp: mwwenwt.reportsanddata.com
RepoDrtisre Actn Ldi nDe:a +ta1 -|2 1W2e-7b1: 0w-1w3w7.0reportsanddata.com
DirecEt -Lminaiel:: s [email protected]
E-mail: [email protected]
Comments